Clinical features of reticular pseudodrusen according to the fundus distribution

British Journal of Ophthalmology

Volumn 96, Issue 9, 2012, Pages 1222-1226

  Lee, MeeYon ^a   Yoon, Jaemoon ^b   Ham, Don Il ^b  

^a Chung Ang University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; BLUE CHANNEL EXAMINATION; BRANCHING MORPHOLOGICAL PATTERN; CLINICAL FEATURE; CONFLUENT MORPHOLOGICAL PATTERN; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSE DISTRIBUTION; DISCRETE MORPHOLOGICAL PATTERN; DISEASE CLASSIFICATION; DRUSEN; EYE FUNDUS; FEMALE; FUNDUS COLOR PHOTOGRAPHY; GEOGRAPHIC ATROPHY; HUMAN; INTERMEDIATE DISTRIBUTION; LATE RETINA MACULA AGE RELATED DEGENERATION; LOCALIZED DISTRIBUTION; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NEAR INFRARED FUNDUS AUTOFLUORESCENCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RED FREE FUNDUS AUTOFLUORESCENCE IMAGING; RETICULAR PSEUDODRUSEN; RETINA MACULA AGE RELATED DEGENERATION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TISSUE DISTRIBUTION; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; OPTIC DISK DRUSEN; PREVALENCE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84866140488     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-301207     Document Type: Article

References (26)

1. Mimoun G, Soubrane G, Coscas G. Macular drusen. J Fr Ophtalmol 1990;13:511-30.
2. Arnold JJ, Sarks SH, Killingsworth MC, et al. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 1995;15:183-91.
3. Cohen SY, Dubois L, Tadayoni R, et al. Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation. Br J Ophthalmol 2007;91:354-9.
4. Klein R, Meuer SM, Knudtson MD, et al. The epidemiology of retinal reticular drusen. Am J Ophthalmol 2008;145:317-26.
5. Smith RT, Sohrab MA, Busuioc M, et al. Reticular macular disease. Am J Ophthalmol 2009;148:733-43.
6. Zweifel SA, Spaide RF, Curcio CA, et al. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010;117:303-12.
7. Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina 2010;30:1441-54.
8. Zweifel SA, Imamura Y, Spaide TC, et al. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 2010;117:1775-81.
9. Sarks J, Arnold J, Ho IV, et al. Evolution of reticular pseudodrusen. Br J Ophthalmol 2011;95:979-85.
10. Querques G, Querques L, Martinelli D, et al. Pathologic insights from integrated imaging of reticular pseudodrusen in age-related macular degeneration. Retina 2011;31:518-26.
11. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128-34.
12. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74.
13. Leng T, Rosenfeld PJ, Gregori G, et al. Spectral domain optical coherence tomography characteristics of cuticular drusen. Retina 2009;29:988-93.
14. Lee MY, Yoon J, Ham DI. Clinical characteristics of reticular pseudodrusen in Korean patients. Am J Ophthalmol 2012;153:530-5.
15. Pumariega NM, Smith RT, Sohrab MA, et al. A prospective study of reticular macular disease. Ophthalmology 2011;118:1619-25.
16. Genead MA, Fishman GA, Lindeman M. Spectral-domain optical coherence tomography and fundus autofluorescence characteristics in patients with fundus albipunctatus and retinitis punctata albescens. Ophthalmic Genet 2010;31:66-72.
17. Finger RP, Charbel Issa P, Kellner U, et al. Spectral domain optical coherence tomography in adult-onset vitelliform macular dystrophy with cuticular drusen. Retina 2010;30:1455-64.
18. Clarkso JG. Central Vein Occlusion Study: photographic protocol and early natural history. Trans Am Ophthalmol Soc 1994;92:203-13.
19. Bressler NM, Bressler SB, West SK, et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989;107:847-52.
20. Strahlman ER, Fine SL, Hillis A. The second eye of patients with senile macular degeneration. Arch Ophthalmol 1983;101:1191-3.
21. Sarks SH. Council Lecture. Drusen and their relationship to senile macular degeneration. Aust J Ophthalmol 1980;8:117-30.
22. Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005;123:1570-4.
23. Zhang K, Hopkins JJ, Heier JS, et al. Ciliary neurotrohic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A 2011;108:6241-5.
24. Owen DG, Jarrar Z, Wormald R, et al. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol 2012;96:752-6.
25. Rudnicka AR, Jarrar Z, Wormald R, et al. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a metaanalysis. Ophthalmology 2012;119:571-80.
26. Yang K, Lianq YB, Gao LQ, et al. Prevalence of age-related macular degeneration in a rural Chinese population: the Handan Eye Study. Ophthalmology 2011;118:1395-401.